Drug intoxication during pregnancy: a study with central registries

Area of Science:

• Perinatal Medicine
• Clinical Toxicology
• Reproductive Health

Background:

• Maternal drug intoxication during pregnancy is a significant concern.
• Understanding the impact of drug exposure on fetal development is crucial.
• Previous studies suggest a low teratogenic risk, but further investigation is warranted.

Purpose of the Study:

• To investigate the association between maternal drug intoxication during pregnancy and congenital malformations in infants.
• To assess the impact of drug exposure during critical developmental periods on infant outcomes.
• To evaluate the risk of low birth weight following maternal drug intoxication.

Main Methods:

• Linking national infant birth and hospital discharge registries.
• Identifying infants born to mothers hospitalized for drug intoxication.
• Analyzing exposure timing during the organogenesis period (first trimester).
• Assessing congenital malformations and birth weight in exposed infants.

Main Results:

• 424 infants exposed to maternal drug intoxication were identified.
• 126 infants had exposure during the organ-forming period; 99 due to drug overdosage.
• No congenital malformations were observed in 70 infants exposed to psychoactive drugs, though a 10% risk increase is within the confidence interval.
• Low birth weight effects were noted only after drug complications during weeks 12-30.

Conclusions:

• Maternal drug intoxication during pregnancy does not appear to carry a substantial teratogenic risk.
• Psychoactive drug exposure during early pregnancy did not result in congenital malformations.
• Specific drug complications later in pregnancy may be associated with low birth weight.